
		From Wikipedia, the free encyclopedia
		
		
		
		
		Jump to navigation
		Jump to search
		English medical scientist and immunologist



.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}SirMark WalportFRS FRCP FRCPath FMedSci FRSEMark WalportBornMark Jeremy Walport (1953-01-25) 25 January 1953 (age 69)[1]London, EnglandEducationSt Paul's School, LondonAlma materUniversity of Cambridge (PhD)[1]Known for
Director of Wellcome Trust (2003–2013)[2]
Government Chief Scientific Adviser (2013–2017)[3]
Spouse(s)Julia Elizabeth Neild
   ​ ​(m. 1986)​[1]Childrenone son, three daughters[1]Awards
Fellow of the Academy of Medical Sciences (1998)
Knight Bachelor (2009)
Fellow of the Royal Society (2011)[4]
Scientific careerFieldsImmunologyRheumatologyInstitutions
Hammersmith Hospital
Royal Brompton Hospital
Guy's Hospital
Imperial College London
Imperial College School of Medicine
Wellcome Trust
University of Cambridge
Government of the United Kingdom
ThesisThe biology of complement receptors (1986)Doctoral advisorPeter Lachmann[5]
Websitegov.uk/government/people/mark-walportSir Mark Jeremy Walport FRS FRCP FRCPath FMedSci FRSE (born 25 January 1953[1]) is an English medical scientist and was the Government Chief Scientific Adviser in the United Kingdom from 2013 to 2017[3][6][7][8][9][10][11][12] and Chief Executive of UK Research and Innovation (UKRI) from 2017[13] to 2020.[14]
Contents

1 Education
2 Career and research

2.1 Honours and awards


3 References



Education[edit]
Walport is the son of a general practitioner and was born in London. He was educated at St Paul's School, London,[1] studied medicine at Clare College, Cambridge, and completed his clinical training at Hammersmith, Guy's and Brompton Hospitals in London.[15][16] He was awarded a PhD for research into complement receptors under the supervision of Peter Lachmann in 1986 at the University of Cambridge.[17]

Career and research[edit]
Previously Walport was Director of the Wellcome Trust from 2003 to 2013.[2] Before this, he was Professor of Medicine (from 1991) and Head of the Division of Medicine (from 1997) at Imperial College London,[15] where he led a research team that focused on the immunology and genetics of rheumatic diseases.[18][19][20][21][22][23][24][25]
Walport was the eleventh Government Chief Scientific Adviser from 2013 to 2017, succeeding Sir John Beddington.
It was announced in February 2017 that Mark Walport is now Chief Executive of UK Research and Innovation (UKRI).[13]

Honours and awards[edit]
Walport was knighted in the 2009 New Year Honours list for services to medical research. He was elected an Honorary Fellow of the Royal Society of Edinburgh (FRSE) in 2017[26] and a Fellow of the Royal Society (FRS) in 2011.[4][15] His nomination for the Royal Society reads: .mw-parser-output .templatequote{overflow:hidden;margin:1em 0;padding:0 40px}.mw-parser-output .templatequote .templatequotecite{line-height:1.5em;text-align:left;padding-left:1.6em;margin-top:0}Mark Walport has an overwhelming case for election both for his earlier scientific work on the immunology of systemic LE and the role of complement and of defective apoptosis in its pathogenesis; and, as a general candidate, for his achievements as head of medicine at the Hammersmith Campus of Imperial College and since 2003 as Director of the Wellcome Trust. In the latter role he has provided national and international leadership at the highest level on biomedical research and policy issues and is widely recognised as a world leader in the promotion of biomedical science.[4]
References[edit]
.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}

^ Jump up to: a b c d e f .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}Anon (2015). "Walport, Sir Mark (Jeremy)". Who's Who. ukwhoswho.com (online Oxford University Press ed.). A & C Black, an imprint of Bloomsbury Publishing plc. doi:10.1093/ww/9780199540884.013.U38753. (Subscription or UK public library membership required.) (subscription required)

^ Jump up to: a b Vogel, Gretchen (2003). "United Kingdom: Mark Walport to Take Reins at Wellcome Trust". Science. 299 (5608): 803a–. doi:10.1126/science.299.5608.803a. PMID 12574591. S2CID 70581694.

^ Jump up to: a b Callaway, Ewen (2012). "Britain names next chief science adviser: Immunologist Mark Walport, head of one of the world's largest biomedical charities, will take on role in 2013". Nature. 487 (7405): 20. doi:10.1038/487020a. PMID 22763530.

^ Jump up to: a b c Anon (2011). "Sir Mark Walport". Royal Society. Retrieved 5 July 2012. One or more of the preceding sentences incorporates text from the royalsociety.org website where: “All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License.” --Royal Society Terms, conditions and policies at the Wayback Machine (archived 2016-11-11)

^ Reed, Tanya (11 July 2003). "Wellcome to a new beginning". Reporter: The newspaper of Imperial College London. No. 131.

^ Mayor, S. (2012). "Mark Walport will be next UK government chief scientific adviser, cabinet office announces". BMJ. 345: e4621. doi:10.1136/bmj.e4621. PMID 22767620. S2CID 11529948.

^ Kain, K. H. (2010). "Funding scientific discovery: An interview with Sir Mark Walport". Disease Models & Mechanisms. 3 (5–6): 265–267. doi:10.1242/dmm.005710. PMID 20427555.

^ Anon (2012). "Good advice: The UK government's latest appointment offers hope for British science". Nature. 487 (7405): 5–6. doi:10.1038/487005b. PMID 22763508.

^ Gibney, Elizabeth (29 June 2012). "New chief scientific adviser announced". Times Higher Education.

^ Mark Walport's publications indexed by the Scopus bibliographic database. (subscription required)

^ Sir Mark Walport in conversation with David Cleevely, Centre for Science and Policy (CSaP) University of Cambridge on YouTube

^ Boulton, G.; Rawlins, M.; Vallance, P.; Walport, M. (2011). "Science as a public enterprise: The case for open data". The Lancet. 377 (9778): 1633–1635. doi:10.1016/S0140-6736(11)60647-8. PMID 21571134. S2CID 3048048.

^ Jump up to: a b "Sir Mark Walport will lead UK Research and Innovation". www.gov.uk (Press release). 2 February 2017. Retrieved 4 July 2017.

^ "Dominic Cummings' science obsession: based on fact or fiction?". Times Higher Education (THE). 16 October 2019. Retrieved 25 November 2019.

^ Jump up to: a b c "Dr Sir Mark Walport". Debrett's. Retrieved 14 February 2012.

^ Morris, K. (2003). "Mark Walport". The Lancet. 362 (9382): 498–499. doi:10.1016/S0140-6736(03)14090-1. PMID 12927451. S2CID 10861093.

^ Walport, Mark Jeremy (1986). The biology of complement receptors (PhD thesis). University of Cambridge. OCLC 59761908. EThOS uk.bl.ethos.383309.

^ "Mark Walport, PhD, MB. BChir., Member, Scientific Board". Grand Challenges in Global Health. Archived from the original on 27 September 2013. Retrieved 14 February 2012.

^ Walport, M.; Foulkes, I.; Weissberg, P.; Morgan, D.; Nebhrajani, S. (2012). "Medical research: No catch to UK charity funding". Nature. 482 (7385): 308. Bibcode:2012Natur.482..308W. doi:10.1038/482308a. PMID 22337042.

^ Collins, P. Y.; Patel, V.; Joestl, S. S.; March, D.; Insel, T. R.; Daar, A. S.; Scientific Advisory Board the Executive Committee of the Grand Challenges on Global Mental Health; Bordin, I. A.; Anderson, E. J.; Dhansay, M.; Phillips, C.; Shurin, R. I.; Walport, W.; Ewart, Y.; Savill, S. E.; Bordin, K.; Costello, S.; Durkin, S.; Fairburn, A.; Glass, A.; Hall, A.; Huang, M. M.; Hyman, V.; Jamison, B. J.; Kaaya, S.; Kapur, P. A.; Kleinman, D. J.; Ogunniyi, W.; Otero-Ojeda, M. A.; Poo, W.; Ravindranath, A. (2011). "Grand challenges in global mental health". Nature. 475 (7354): 27–30. doi:10.1038/475027a. PMC 3173804. PMID 21734685.

^ Yamada, T.; Dautry, A.; Walport, M. (2008). "Ready for avian flu?". Nature. 454 (7201): 162. Bibcode:2008Natur.454..162Y. doi:10.1038/454162a. PMID 18615064. S2CID 205039550.

^ Pickering, M. C.; Warren, J.; Rose, K. L.; Carlucci, F.; Wang, Y.; Walport, M. J.; Cook, H. T.; Botto, M. (2006). "Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice". Proceedings of the National Academy of Sciences. 103 (25): 9649–9654. Bibcode:2006PNAS..103.9649P. doi:10.1073/pnas.0601094103. PMC 1476693. PMID 16769899.

^ Brown, J. S.; Hussell, T.; Gilliland, S. M.; Holden, D. W.; Paton, J. C.; Ehrenstein, M. R.; Walport, M. J.; Botto, M. (2002). "The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice". Proceedings of the National Academy of Sciences. 99 (26): 16969–16974. Bibcode:2002PNAS...9916969B. doi:10.1073/pnas.012669199. PMC 139253. PMID 12477926.

^ Botto, M.; Fong, K. Y.; So, A. K.; Barlow, R.; Routier, R.; Morley, B. J.; Walport, M. J. (1992). "Homozygous hereditary C3 deficiency due to a partial gene deletion". Proceedings of the National Academy of Sciences of the United States of America. 89 (11): 4957–4961. Bibcode:1992PNAS...89.4957B. doi:10.1073/pnas.89.11.4957. PMC 49207. PMID 1350678.

^ Taylor, P. R.; Carugati, A.; Fadok, V. A.; Cook, H. T.; Andrews, M.; Carroll, M. C.; Savill, J. S.; Henson, P. M.; Botto, M.; Walport, M. J. (2000). "A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo". Journal of Experimental Medicine. 192 (3): 359–366. doi:10.1084/jem.192.3.359. PMC 2193213. PMID 10934224.

^ "RSE Welcomes 60 New Fellows" (Press release). Royal Society of Edinburgh. 15 February 2017. Retrieved 28 March 2017.


 This article incorporates text available under the CC BY 4.0 license.



Government offices


Preceded byJohn Beddington

 Government Chief Scientific Adviser 2013−2017

Succeeded byChris WhittyActing




Cultural offices


Preceded byMichael Dexter

 Director of Wellcome Trust 2003–2013

Succeeded byJeremy Farrar


.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}show.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}vteFellows of the Royal Society elected in 2011Fellows
Robin Allshire
Andrew Balmford
Jeremy Baumberg
Hagan Bayley
Béla Bollobás
Doreen Cantrell
Stan Cowley
Alan Cowman
Alun Davies
Nicholas Franks
Ian Frazer
Steven Gamblin
John Goodby
Alan Grafen
Clare Grey
Janet Hemingway
Ian Horrocks
Colin Humphreys
Alex Kacelnik
Robert Kennicutt
Steffen Lauritzen
Dennis Lo
Ian Manners
David Manolopoulos
Gerhard Materlik
James McKernan
Tom McLeish
David McMurtry
Mervyn Miles
Arthur Milner
John Morton
Sean Munro
Werner Nahm
Konstantin Novoselov
Mark Pagel
John Parkes
Fiona Powrie
Mark Randolph
Len Stephens
Patrick Tam
Simon Tavaré
Angela Vincent
Mark Walport
Robert Watson
Foreign
David Chandler
Joanne Chory
Mikhail Gromov
Thomas Hughes
Phillip Allen Sharp
Carla J. Shatz
Thomas A. Steitz
Edward Stolper

showvteWellcome TrustCentres and institutesCurrent
Francis Crick Institute
Gurdon Institute
Sainsbury Wellcome Centre for Neural Circuits and Behaviour
Science Learning Centres
WTC for Cell-Matrix Research
WTC for Gene Regulation and Expression
WTC for Human Genetics
WTC for Mitochondrial Research
WTC for Molecular Parasitology
WTC for Neuroimaging
WTC for Stem Cell Research
Wellcome Sanger Institute
Former
Wellcome Trust Centre for the History of Medicine
Wellcome Research Laboratories
Projects and facilities
1000 Genomes Project
Big Picture
Cambridge Biomedical Campus
Cancer Genome Project
ChEMBL
Coalition for Epidemic Preparedness Innovations
COSMIC cancer database
DECIPHER
Diamond Light Source
eLife
Ensembl
Farmcare
Genome Reference Consortium
Human Genome Project
Malawi Liverpool Wellcome Trust
MEROPS
Pfam
Rfam
UK Biobank
Wellcome Collection
Wellcome Genome Campus
Wellcome Library
WormBase
Board of Governors
Eliza Manningham-Buller
Michael Ferguson
Tobias Bonhoeffer
Alan Brown
William Burns
Bryan Grenfell
Naguib Kheraj
Fiona Powrie
Executive Leadership Team
Jeremy Farrar
Chris Bird
Stephen Caddick
Simon Chaplin
Alyson Fox
Peter Pereira Gray
Mark Henderson
Chonnettia Jones
Tim Livett
Nick Moakes
Kathy Poole
Jim Smith
James Thomas
Ed Whiting
Former directors
Peter Williams (1965–1991)
Bridget Ogilvie (1991–1998)
Michael Dexter (1998–2008)
Mark Walport (2003–2013)
Other key people
Damon Buffini
William Castell
Dominic Cadbury
Harold Cook
Kay Davies
Oliver Franks
Roger Gibbs
Henry Dale
Richard Hynes
Anne Johnson
Roy Porter
Peter Rigby
David Steel
David Stuart
John Sulston
Henry Wellcome
Awards and fellowships
Capital Awards
Collaborative Awards in Science
Investigator Awards in Science
Institutional Strategic Support Fund
Science Strategic Award
Sir Henry Dale Fellowship
Sir Henry Wellcome Postdoctoral Fellowship
Wellcome Book Prize
Wellcome Image Awards
Wellcome Trust Centre
Wellcome Trust Principal Research Fellow
Wellcome Trust Senior Research Fellow
 Category
showAuthority control General
ISNI
1
ORCID
1
VIAF
1
WorldCat
National libraries
France (data)
United States
Czech Republic
Korea
Netherlands
Scientific databases
Scopus author
Other
SUDOC (France)
1





<img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" />
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mark_Walport&oldid=1065715074"
		Categories: 1953 birthsLiving peopleMedical doctors from LondonAlumni of Clare College, CambridgeBritish immunologistsBritish rheumatologistsWellcome TrustAcademics of Imperial College LondonKnights BachelorFellows of the Academy of Medical Sciences (United Kingdom)Fellows of the Royal SocietyPeople educated at St Paul's School, LondonFellows of the Royal Society of EdinburghFellows of the Royal College of PhysiciansHidden categories: Pages containing links to subscription-only contentWebarchive template wayback linksArticles with short descriptionShort description is different from WikidataEngvarB from June 2017Use dmy dates from June 2017Articles with hCardsArticles with imported freely licensed textArticles with ISNI identifiersArticles with ORCID identifiersArticles with VIAF identifiersArticles with WORLDCATID identifiersArticles with BNF identifiersArticles with LCCN identifiersArticles with NKC identifiersArticles with NLK identifiersArticles with NTA identifiersArticles with Scopus identifiersArticles with SUDOC identifiers
	